Projects per year
Abstract
OBJECTIVES: To assess the agreement between pharmaceutical claims data and patient-reported medication use after stroke. METHODS: Claims data from the Pharmaceutical Benefits Scheme were used to estimate medication use for a subset of participants registered in the Australian Stroke Clinical Registry in 2016. Estimates on medication use were validated against patient-reported responses (considered the reference standard). KEY FINDINGS: For antihypertensive and lipid-lowering medications, the sensitivity of claims data was excellent (85-87%) and the specificity was good (73-78%). Whereas for antithrombotic medications, sensitivity was modest (61%), but specificity was excellent (85%). CONCLUSIONS: Pharmaceutical claims data can be used to infer medication use after stroke with mostly good to excellent sensitivity and specificity compared with the patient report.
| Original language | English |
|---|---|
| Pages (from-to) | 397-399 |
| Number of pages | 3 |
| Journal | International Journal of Pharmacy Practice |
| Volume | 29 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Aug 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- administrative claims
- healthcare validation study
- pharmacoepidemiology
- registries
- stroke
Projects
- 1 Finished
-
PRECISE: Evaluation of enhanced models of primary care in the management of stroke and other chronic diseases
Andrew, N. (Primary Chief Investigator (PCI)), Kilkenny, M. (Chief Investigator (CI)) & Kim, J. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/18 → 31/12/21
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver